NeuBase Therapeutics, Inc. announced that on June 26, 2024, Dietrich A. Stephan, Ph.D., Gerald J. McDougall and Eric I. Richman notified the Company of their resignation as a member of the Board, effective immediately. Such resignations did not result from any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3406 EUR | -0.58% | -.--% | -45.94% |
06-27 | NeuBase Therapeutics, Inc. Announces Board Resignations | CI |
05-29 | NeuBase Therapeutics, Inc. announced that it has received $0.000001 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-45.94% | 1.39M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- O7P Stock
- News NeuBase Therapeutics, Inc.
- NeuBase Therapeutics, Inc. Announces Board Resignations